Stock listing
NASDAQ:ELVN Enliven Therapeutics, Inc. Stock
Home listing (NASDAQ) of Enliven Therapeutics, Inc.
Follow Enliven Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ELVN
$41.25 USD +2.55 (+6.6%)
Close on Oct 20, 2026
- Day range
- $38.41 – $41.37 USDOct 20, 2026
- Volume
- 1.94M sharesOct 20, 2026
- Market cap
- $3.02B USDAt the close on Oct 20, 2026 · price × 73.27M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ELVN · Home | $41.25 USD | +2.55 (+6.6%) | 1,938,204 | $38.86 | $41.37 | $38.41 | $38.70 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:ELVN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $41.25 | +2.55 | +6.6% | $38.86 | $41.37 | $38.41 | 1,938,204 | |
| $38.70 | +1.38 | +3.7% | $38.01 | $38.83 | $37.50 | 1,312,313 | |
| $37.32 | -2.01 | -5.1% | $39.33 | $39.47 | $36.96 | 1,188,443 | |
| $39.33 | +0.05 | +0.1% | $39.48 | $40.29 | $38.49 | 2,053,736 | |
| $39.28 | -0.21 | -0.5% | $38.99 | $39.95 | $38.51 | 1,217,094 | |
| $39.49 | -1.35 | -3.3% | $40.56 | $40.99 | $39.27 | 847,875 | |
| $40.84 | -0.14 | -0.3% | $40.67 | $41.41 | $40.50 | 579,824 | |
| $40.98 | +0.35 | +0.9% | $41.00 | $42.06 | $40.29 | 1,002,682 | |
| $40.63 | -0.73 | -1.8% | $40.90 | $40.90 | $39.25 | 1,651,554 | |
| $41.36 | -1.03 | -2.4% | $41.62 | $42.38 | $41.04 | 1,461,362 | |
| $42.39 | -3.08 | -6.8% | $45.38 | $45.61 | $41.22 | 2,333,092 | |
| $45.47 | -1.50 | -3.2% | $46.94 | $46.94 | $45.23 | 821,505 | |
| $46.97 | +0.76 | +1.6% | $47.38 | $47.43 | $45.92 | 1,123,208 | |
| $46.21 | +0.37 | +0.8% | $46.29 | $47.23 | $45.70 | 944,890 | |
| $45.84 | -0.67 | -1.4% | $46.98 | $46.98 | $45.47 | 800,171 | |
| $46.51 | +0.50 | +1.1% | $46.01 | $46.87 | $45.41 | 1,256,237 | |
| $46.01 | +1.26 | +2.8% | $44.38 | $46.90 | $44.19 | 1,284,648 | |
| $44.75 | -0.42 | -0.9% | $45.54 | $45.77 | $44.18 | 963,790 | |
| $45.17 | -0.92 | -2.0% | $45.90 | $46.52 | $44.81 | 749,360 | |
| $46.09 | -2.10 | -4.4% | $47.84 | $48.03 | $45.66 | 1,550,858 | |
| $48.19 | -0.68 | -1.4% | $49.07 | $49.13 | $47.70 | 1,213,439 | |
| $48.87 | -0.58 | -1.2% | $49.45 | $49.52 | $47.98 | 2,281,266 | |
| $49.45 | -0.79 | -1.6% | $50.15 | $51.20 | $49.19 | 6,005,806 | |
| $50.24 | +1.12 | +2.3% | $49.58 | $51.83 | $49.32 | 1,963,463 | |
| $49.12 | -4.24 | -7.9% | $53.70 | $54.13 | $48.42 | 2,914,713 | |
| $53.36 | -1.07 | -2.0% | $54.32 | $54.50 | $52.98 | 866,959 | |
| $54.43 | +0.11 | +0.2% | $55.00 | $55.83 | $54.01 | 858,163 | |
| $54.32 | -1.91 | -3.4% | $57.00 | $57.00 | $54.12 | 995,816 | |
| $56.23 | -1.22 | -2.1% | $57.15 | $57.82 | $56.05 | 769,641 | |
| $57.45 | -1.92 | -3.2% | $59.05 | $59.96 | $57.29 | 1,293,938 | |
| $59.37 | +0.05 | +0.1% | $58.75 | $59.90 | $58.24 | 1,325,966 | |
| $59.32 | -0.33 | -0.6% | $59.69 | $59.89 | $58.97 | 1,113,062 | |
| $59.65 | +0.64 | +1.1% | $58.88 | $60.10 | $58.66 | 806,100 | |
| $59.01 | +1.15 | +2.0% | $58.36 | $60.55 | $57.36 | 609,969 | |
| $57.86 | -0.03 | -0.1% | $57.99 | $58.45 | $57.23 | 1,056,445 | |
| $57.89 | +0.03 | +0.1% | $57.50 | $58.79 | $56.33 | 982,050 | |
| $57.86 | -2.64 | -4.4% | $60.40 | $61.18 | $57.73 | 584,982 | |
| $60.50 | -0.365 | -0.6% | $60.76 | $61.82 | $60.46 | 524,066 | |
| $60.87 | -0.145 | -0.2% | $61.03 | $61.80 | $59.79 | 1,001,130 | |
| $61.01 | -0.14 | -0.2% | $61.90 | $62.00 | $60.57 | 804,386 | |
| $61.15 | +1.33 | +2.2% | $59.77 | $61.99 | $59.47 | 1,255,225 | |
| $59.82 | +0.90 | +1.5% | $59.00 | $60.00 | $58.83 | 596,369 | |
| $58.92 | -0.47 | -0.8% | $58.95 | $59.54 | $57.07 | 945,520 | |
| $59.39 | -0.68 | -1.1% | $61.01 | $61.21 | $58.39 | 939,740 | |
| $60.07 | +0.535 | +0.9% | $59.79 | $60.44 | $59.01 | 619,313 | |
| $59.54 | +0.715 | +1.2% | $58.71 | $59.65 | $57.92 | 529,479 | |
| $58.82 | +0.76 | +1.3% | $57.67 | $58.90 | $56.69 | 350,290 | |
| $58.06 | +0.14 | +0.2% | $58.54 | $58.73 | $57.70 | 595,093 | |
| $57.92 | -0.86 | -1.5% | $59.09 | $60.38 | $57.68 | 1,010,951 | |
| $58.78 | -0.64 | -1.1% | $59.25 | $59.27 | $57.39 | 1,277,496 | |
| $59.42 | -1.04 | -1.7% | $59.89 | $60.99 | $58.52 | 620,956 | |
| $60.46 | +0.19 | +0.3% | $60.18 | $61.77 | $59.73 | 696,100 | |
| $60.27 | +0.57 | +1.0% | $59.34 | $61.86 | $59.11 | 1,679,228 | |
| $59.70 | -1.41 | -2.3% | $61.01 | $62.32 | $57.47 | 1,724,208 | |
| $61.11 | +3.07 | +5.3% | $58.58 | $61.29 | $57.54 | 2,527,886 | |
| $58.04 | +3.23 | +5.9% | $54.85 | $59.72 | $52.73 | 2,841,266 | |
| $54.81 | +0.86 | +1.6% | $54.10 | $55.82 | $53.10 | 660,426 | |
| $53.95 | +0.98 | +1.9% | $53.04 | $54.81 | $52.75 | 648,090 | |
| $52.97 | -0.79 | -1.5% | $53.99 | $54.50 | $52.20 | 854,006 | |
| $53.76 | +1.025 | +1.9% | $52.85 | $54.12 | $52.00 | 727,219 | |
| $52.74 | -0.215 | -0.4% | $53.41 | $55.79 | $52.54 | 1,408,411 | |
| $52.95 | +0.14 | +0.3% | $53.15 | $53.71 | $51.74 | 368,766 | |
| $52.81 | -0.04 | -0.1% | $52.23 | $53.44 | $51.59 | 656,028 | |
| $52.85 | -1.48 | -2.7% | $54.01 | $54.27 | $52.77 | 448,188 | |
| $54.33 | +2.66 | +5.1% | $52.23 | $54.88 | $51.97 | 636,621 | |
| $51.67 | -1.53 | -2.9% | $52.55 | $53.45 | $51.39 | 581,022 |
- Ticker
- NASDAQ:ELVN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
Latest deck · Oct 5, 2026
Investor Presentation (October 2026)
Investor deck · 29 slides
Calls
Replays
IMARA Inc. (IMRA) Q4 2021 Earnings Call
Tue, Mar 15, 2022 · 8:30 AM ET
Watch TranscriptIMARA Inc. (IMRA) Q3 2021 Earnings Call
Tue, Nov 09, 2021 · 8:30 AM ET
Watch TranscriptIMARA Inc. (IMRA) Q2 2021 Earnings Call
Fri, Aug 06, 2021 · 8:30 AM ET
Watch Transcript
Latest news
Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year
Oct 14, 2026
Closed $39.33 (+0.1%) on Oct 15, 2026
Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia
Oct 6, 2026
Closed $41.36 (-2.4%) on Oct 7, 2026
Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
Aug 31, 2026
Closed $57.86 (-0.1%) on Sep 1, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 29 slides · Oct 5, 2026
EHA 2026 Congress
Conference · 33 slides · Jun 11, 2026
SOHO 2025
Conference · 16 slides · September 2025
Technical Presentation (June 2025)
Technical · 43 slides · Jun 13, 2025
Enliven Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 99 in all · newest Oct 14, 2026 · oldest 2020
- Calls
- 6 calls with a replay · 6 with a transcript · latest Mar 15, 2022
- Decks
- 6 decks · latest Oct 5, 2026
Where Enliven Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ELVN · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ELVN | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Enliven Therapeutics, Inc.